Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Sabre $1.325 billion notes offering and concurrent cash tender offer
We advised Sabre on its high-yield notes offering and on a debt tender offer
Fever acquisition of DICE
We are advising Fever on the acquisition
Pacific Gas and Electric $1.25 billion first-mortgage bonds offering
The investment-grade bonds are due 2028 and 2035
Eos Energy $86 million stock offering and $225 million convertible notes offering
We advised Eos Energy on the concurrent offerings
Ventas $500 million senior notes offering
We advised Ventas on its investment-grade debt offering
Galaxy $600 million stock offering
We advised Galaxy on its first underwritten public offering as a listed company on Nasdaq
Equinor $1.75 billion notes offering
The investment-grade notes are due 2028, 2030 and 2035
Clarivate $500 million incremental term loan facility
We advised the borrower on the transaction
JENA Acquisition Corporation II $230 million IPO
The units were listed on the New York Stock Exchange
General Motors Financial $2.25 billion senior notes offering
The investment-grade notes are due 2027, 2030 and 2035